Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Cytolysis”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Early research (Phase 1)Looking for participantsNCT06376474
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 24
Early research (Phase 1)Looking for participantsNCT06952634
What this trial is testing

An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

Who this might be right for
Hepatic Impairment
Alumis Inc 48
Not applicableLooking for participantsNCT04036357
What this trial is testing

Liver Damage and Cardiometabolic Disorders in NAFLD

Who this might be right for
NAFLDLiver FibrosesCardiovascular Diseases+1 more
University of Roma La Sapienza 2,000
Not applicableUnknownNCT05861375
What this trial is testing

Liver Biomarkers in Anorexia Nervosa

Who this might be right for
Anorexia Nervosa
Nantes University Hospital 50
Not applicableUnknownNCT00842205
What this trial is testing

Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic HCV InfectionNonalcoholic Steatohepatitis
Charles University, Czech Republic 150
Early research (Phase 1)UnknownNCT05427682
What this trial is testing

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage

Who this might be right for
Diabetes Mellitus, Type 2
Sunshine Lake Pharma Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT06409130
What this trial is testing

Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease

Who this might be right for
Alcohol-related Liver Disease
Novo Nordisk A/S 270
Early research (Phase 1)Study completedNCT05976321
What this trial is testing

TAK-279 in Adults With or Without Liver Damage

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Takeda 27
Not applicableStudy completedNCT00166608
What this trial is testing

Cytokines Polymorphisms and Acetaminophen Toxicity

Who this might be right for
Drug Toxicity
Arkansas Children's Hospital Research Institute 111
Not applicableLooking for participantsNCT00360646
What this trial is testing

Drug-Induced Liver Injury (DILI) Network Retrospective

Who this might be right for
Drug Induced Liver Injury
Duke University 400
Not applicableStudy completedNCT01274520
What this trial is testing

Hypothermic Machine Preservation-Phase 2

Who this might be right for
Liver Damage
Columbia University 24
Testing effectiveness (Phase 2)Study completedNCT03987451
What this trial is testing

A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage

Who this might be right for
Non-alcoholic Steatohepatitis
Novo Nordisk A/S 71
Not applicableNot Yet RecruitingNCT06089785
What this trial is testing

Elastography in Liver Cell Failure

Who this might be right for
Liver Cell Damage
Omnia Saad Desoky Mohamed 77
Post-approval studies (Phase 4)Study completedNCT01166633
What this trial is testing

Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
JW Pharmaceutical 200
Testing effectiveness (Phase 2)Study completedNCT00668369
What this trial is testing

Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Who this might be right for
Hepatitis C Virus InfectionLiver Transplantation
Hospital Clinic of Barcelona 34
Not applicableStudy completedNCT06611046
What this trial is testing

MicroRNA Profile As a Biomarker of Liver Damage in Different Types of Liver Donors.

Who this might be right for
MicroRNA ProfileLiver TransplantOrgan Donor
Mar Dalmau 28
Not applicableLooking for participantsNCT06262165
What this trial is testing

Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis

Who this might be right for
Anorexia Nervosa
Nantes University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00003966
What this trial is testing

Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation

Who this might be right for
Veno-occlusive Disease
Dana-Farber Cancer Institute 151
Early research (Phase 1)Study completedNCT02300025
What this trial is testing

Evaluate the Pharmacokinetics and Safety of Cobimetinib in Volunteers With and Without Liver Damage

Who this might be right for
Healthy Volunteer
Genentech, Inc. 28
Post-approval studies (Phase 4)Not Yet RecruitingNCT06974396
What this trial is testing

Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage

Who this might be right for
Hemorrhagic Disorders
University Hospital, Strasbourg, France 20
Load More Results